146 related articles for article (PubMed ID: 11979737)
1. [A case of Hodgkin's disease of mesenteric origin].
Morita M; Tani S; Hagihara R; Ryu Y; Yagi N; Yamashita J; Imanishi K; Kitazawa S
Nihon Shokakibyo Gakkai Zasshi; 2002 Apr; 99(4):391-6. PubMed ID: 11979737
[No Abstract] [Full Text] [Related]
2. Chemotherapy for Hodgkin's disease.
Ekert H
N Engl J Med; 2003 Sep; 349(12):1186-7; author reply 1186-7. PubMed ID: 13679536
[No Abstract] [Full Text] [Related]
3. The case against the routine use of radiation therapy in advanced-stage Hodgkin's disease.
Longo DL
Cancer Invest; 1996; 14(4):353-60. PubMed ID: 8689431
[No Abstract] [Full Text] [Related]
4. [Laparotomy with splenectomy in the evaluation of the results of cytostatic treatment of patients with advanced Hodgkin's disease].
Płuzańska A; Berner J; Kowalczyński M; Dowgier-Witczak I; Chmielowska E; Woźniak L
Pol Arch Med Wewn; 1986 May; 75(5):344-50. PubMed ID: 2431397
[No Abstract] [Full Text] [Related]
5. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V
Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy: Advanced Hodgkin lymphoma--balancing toxicity and cure.
Lim SH; Johnson PW
Nat Rev Clin Oncol; 2011 Sep; 8(11):634-6. PubMed ID: 21894205
[No Abstract] [Full Text] [Related]
7. [Treatment of advanced Hodgkin lymphoma].
Kreissl S; Borchmann P
Dtsch Med Wochenschr; 2013 Jun; 138(23):1212-4. PubMed ID: 23720173
[No Abstract] [Full Text] [Related]
8. Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?
Carde P; Cavalli F; Diehl V; Franklin J
Hematol J; 2000; 1(4):282-90. PubMed ID: 11920203
[No Abstract] [Full Text] [Related]
9. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
Constine LS
J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
[No Abstract] [Full Text] [Related]
10. [Rescue treatment in Hodgkin's disease].
Zori Comba A; Koziner B
Sangre (Barc); 1987; 32(1):67-76. PubMed ID: 2438788
[No Abstract] [Full Text] [Related]
11. Treatment of advanced stage Hodgkin lymphoma--it's all about risk-benefit.
Phipps C; Lee YS; Hwang W
Br J Haematol; 2012 Oct; 159(1):113-5. PubMed ID: 22823109
[No Abstract] [Full Text] [Related]
12. Long-term follow-up of survival in Hodgkin's lymphoma.
Canellos GP; Niedzwiecki D; Johnson JL
N Engl J Med; 2009 Dec; 361(24):2390-1. PubMed ID: 20007568
[No Abstract] [Full Text] [Related]
13. Chemotherapy: Hodgkin lymphoma--absence of evidence not evidence of absence!
Borchmann P; Engert A; Diehl V
Nat Rev Clin Oncol; 2011 Oct; 8(11):636-7. PubMed ID: 21971592
[No Abstract] [Full Text] [Related]
14. Chemotherapy combined with involved-field radiotherapy for 177 children with Hodgkin's disease treated in 1983-1987.
Balwierz W; Armata J; Moryl-Bujakowska A; Depowska T; Najbar A; Radwańska U; Kaczmarek M; Ochocka M; Stańczak E; Sońta-Jakimczyk D
Acta Paediatr Jpn; 1991 Dec; 33(6):703-8. PubMed ID: 1724869
[No Abstract] [Full Text] [Related]
15. [Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
Suon SZ
Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):117-120, contd. PubMed ID: 2580675
[No Abstract] [Full Text] [Related]
16. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.
Ann Oncol; 2001 Sep; 12(9):1213-4. PubMed ID: 11697828
[No Abstract] [Full Text] [Related]
17. An unusual case of spontaneous remission of Hodgkin's disease after a single cycle of COPP-ABV chemotherapy followed by infectious complications.
Bang SM; Cheong JW; Yang WI; Hahn JS
Yonsei Med J; 2005 Jun; 46(3):425-30. PubMed ID: 15988816
[TBL] [Abstract][Full Text] [Related]
18. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
[TBL] [Abstract][Full Text] [Related]
19. [Controversy regarding the treatment of Hodgkin's disease].
Balwierz W; Armata J
Pol Tyg Lek; 1989 Apr; 44(14):315-9. PubMed ID: 2482966
[No Abstract] [Full Text] [Related]
20. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
Sieber M; Tesch H; Pfistner B; Rueffer U; Lathan B; Brosteanu O; Paulus U; Koch T; Pfreundschuh M; Loeffler M; Engert A; Josting A; Wolf J; Hasenclever D; Franklin J; Duehmke E; Georgii A; Schalk KP; Kirchner H; Doelken G; Munker R; Koch P; Herrmann R; Greil R; Anselmo AP; Diehl V
J Clin Oncol; 2002 Jan; 20(2):476-84. PubMed ID: 11786577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
